PIF, a tumor-derived factor detected in the urine of patients with cancer cachexia, can reduce protein synthesis by activating the double-stranded RNA-dependent protein kinase (PKR)/phospholipase A2 pathway and can increase protein degradation by promoting nuclear accumulation of NFκB and the ubiquitin-proteasome pathway [37,40]. The gene discussed is DCD; the disease is neoplasm.